Author details

Full Name

Matthew Ducar

Affiliation

ORCID

Career Start Year

2001

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35084050	Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.	Prostate	2022
33414136	Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions.	Clin Cancer Res	2021
33625877	OncoTree: A Cancer Classification System for Precision Oncology.	JCO Clin Cancer Inform	2021
34203201	Dissection of <i>PIK3CA</i> Aberration for Cervical Adenocarcinoma Outcomes.	Cancers (Basel)	2021
32467349	Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma.	Cancer Epidemiol Biomarkers Prev	2020
32068070	ViroPanel: Hybrid Capture and Massively Parallel Sequencing for Simultaneous Detection and Profiling of Oncogenic Virus Infection and Tumor Genome.	Journal of Molecular Diagnostics	2020
29961768	Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.	Genet Med	2019
31697821	Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade.	Blood	2019
31816062	Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.	Blood Adv	2019
30801050	Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade.	JCO Precis Oncol	2018
28978556	Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.	Cancer Discov	2018
29955181	Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29955182	Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
30126979	Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.	Blood	2018
29098284	Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.	JAMA Oncol	2018
29310587	Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing.	BMC Genomics	2018
29713087	Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29477794	Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.	European Journal of Cancer	2018
29608884	Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.	Gastroenterology	2018
29654263	Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia.	Leukemia	2018
29461635	Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.	Cancer	2018
28114446	Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.	JAMA Oncol	2017
28557599	Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.		2017
28727266	Next-generation sequencing of cytologic preparations: An analysis of quality metrics.	Cancer cytopathology	2017
28713588	Genomic landscape of high-grade meningiomas.	NPJ Genom Med	2017
28486603	Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors.	Endocrinology	2017
29263836	Erratum: Genomic landscape of high-grade meningiomas.	NPJ Genom Med	2017
29156750	Somatic mutations in <i>CDH1</i> and <i>CTNNB1</i> in primary carcinomas at 13 anatomic sites.	Oncotarget	2017
27707790	Landscape of Genomic Alterations in Pituitary Adenomas.	Clin Cancer Res	2017
28104717	Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.	Neuro Oncol	2017
27882345	Institutional implementation of clinical tumor profiling on an unselected cancer population.	JCI Insight	2016
26829751	MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.	Nat Genet	2016
26773040	Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.	Blood	2016
27460824	The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.	Genome Med	2016
26702065	Targetable genetic features of primary testicular and primary central nervous system lymphomas.	Blood	2016
26256760	Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.	Lancet Oncol	2015
25626421	Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women.	Int J Cancer	2015
25899310	MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis.	Genes Chromosomes and Cancer	2015
25428359	BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers.	Nucleic Acids Res	2015
24652991	Somatic activating ARAF mutations in Langerhans cell histiocytosis.	Blood	2014
25157968	Prospective enterprise-level molecular genotyping of a cohort of cancer patients.	J Mol Diagn	2014
23334667	Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.	Nat Genet	2013
23633565	Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.	Proc Natl Acad Sci U S A	2013
22585170	High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.	Cancer Discov	2012
12606557	Novel peptide inhibitors of angiotensin-converting enzyme 2.	Journal of Biological Chemistry	2003
11329013	Creation of genome-wide protein expression libraries using random activation of gene expression.	Nat Biotechnol	2001